Literature DB >> 16979225

Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.

Derrick L Sauls1, Erin K Arnold, Charles W Bell, Jonathan C Allen, Maureane Hoffman.   

Abstract

Elevated plasma homocysteine levels are associated with the risk of atherosclerosis and arterial and venous thrombosis. We have previously demonstrated that rabbits rendered hyperhomocysteinemic by parenteral administration of homocysteine develop a dysfibrinogenemia that is associated with the formation of fibrin clots that are abnormally resistant to fibrinolysis. We suggested that this acquired dysfibrinogenemia contributes to the thrombotic tendency in hyperhomocysteinemia. However, it was possible that the homocysteine-associated dysfibrinogenemia was an artifact of the parenteral administration model. Therefore, the goals of the current study were to develop a diet-induced model of homocysteinemia in rabbits and determine whether a dysfibrinogenemia and evidence of oxidative stress develop in this model as they do when homocysteine is injected. We found that rabbits fed a diet severely deficient in folate and mildly deficient in choline develop mild hyperhomocysteinemia: 14.8+/-4.0 microM in deficient rabbits compared to 9.0+/-1.7 microM in controls. The deficient rabbits also develop evidence of oxidant stress: increased lipid peroxidation in liver, impaired mitochondrial enzyme activities in liver and elevated caspase-3 levels in plasma. Most importantly, the deficient rabbits also develop a dysfibrinogenemia characterized by increased resistance to fibrinolysis. We believe that this dietary model of homocysteinemia is clinically relevant and reproduces many features associated with hyperhomocysteinemia in previous work using in vitro and in vivo models. Our findings suggest that an acquired dysfibrinogenemia could play a role in the increased risk of atherothrombotic disease in mildly hyperhomocysteinemic human subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979225     DOI: 10.1016/j.thromres.2006.08.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen.

Authors:  Joanna Kołodziejczyk; Joanna Malinowska; Pawel Nowak; Beata Olas
Journal:  Mol Cell Biochem       Date:  2010-07-24       Impact factor: 3.396

Review 2.  Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.

Authors:  Kuangguo Zhou; Ruizhi Zhao; Zhe Geng; Lijun Jiang; Yang Cao; Danmei Xu; Yin Liu; Liang Huang; Jianfeng Zhou
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

3.  Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status.

Authors:  Agnieszka Makówka; Przemysław Dryja; Grażyna Chwatko; Edward Bald; Michał Nowicki
Journal:  Lipids Health Dis       Date:  2012-07-06       Impact factor: 3.876

Review 4.  The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Authors:  Maryam Assem; Mathilde Lando; Maria Grissi; Saïd Kamel; Ziad A Massy; Jean-Marc Chillon; Lucie Hénaut
Journal:  Toxins (Basel)       Date:  2018-07-22       Impact factor: 4.546

5.  Effects of Hyperhomocysteinemia on the Platelet-Driven Contraction of Blood Clots.

Authors:  Rustem I Litvinov; Alina D Peshkova; Giang Le Minh; Nail N Khaertdinov; Natalia G Evtugina; Guzel F Sitdikova; John W Weisel
Journal:  Metabolites       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.